EQUITY RESEARCH MEMO

Origent Data Sciences

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

Origent Data Sciences addresses a critical gap in healthcare: the vast amount of unstructured patient narrative data (clinical notes, patient-reported outcomes) that remains underutilized. Their AI health companion uses natural language processing and machine learning to convert this free-text data into structured, real-time insights. This enables earlier disease detection, more personalized treatment plans, and improved care coordination. By creating a new category of health data, Origent empowers clinicians, payers, and life science companies with actionable intelligence that was previously locked in silos. Founded in 2015 and based in Vienna, Virginia, the company is well-positioned to capitalize on the growing demand for AI-driven clinical decision support, particularly in neuroscience, where patient narratives are rich with diagnostic clues.

Upcoming Catalysts (preview)

  • Q4 2026Strategic partnership with a major health system for pilot deployment70% success
  • Q2 2027Publication of validation study demonstrating clinical utility in neurodegenerative disease60% success
  • Q3 2026Series A funding round to scale commercialization55% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)